Dynamic Technology Lab Private Ltd Buys Shares of 19,447 Health Catalyst, Inc. $HCAT

Dynamic Technology Lab Private Ltd purchased a new position in shares of Health Catalyst, Inc. (NASDAQ:HCAT) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 19,447 shares of the company’s stock, valued at approximately $73,000.

Other institutional investors and hedge funds have also modified their holdings of the company. First Light Asset Management LLC lifted its holdings in Health Catalyst by 99.1% in the first quarter. First Light Asset Management LLC now owns 10,436,807 shares of the company’s stock valued at $47,279,000 after buying an additional 5,195,686 shares during the period. Whetstone Capital Advisors LLC bought a new stake in shares of Health Catalyst during the 1st quarter valued at $7,724,000. Nuveen LLC acquired a new position in shares of Health Catalyst in the 1st quarter valued at $2,674,000. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Health Catalyst by 172.6% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 694,361 shares of the company’s stock worth $3,145,000 after purchasing an additional 439,599 shares during the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of Health Catalyst by 88.8% in the 1st quarter. Acadian Asset Management LLC now owns 930,229 shares of the company’s stock worth $4,211,000 after purchasing an additional 437,536 shares during the last quarter. 85.00% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Evercore ISI dropped their price objective on Health Catalyst from $4.00 to $3.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Health Catalyst in a research note on Monday. Wells Fargo & Company cut their price target on shares of Health Catalyst from $6.00 to $5.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 11th. Cantor Fitzgerald restated a “neutral” rating and set a $4.00 price objective on shares of Health Catalyst in a report on Tuesday, October 7th. Finally, Piper Sandler downgraded shares of Health Catalyst from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $8.00 to $4.00 in a research note on Wednesday, August 27th. Five investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $4.36.

Health Catalyst Price Performance

Shares of HCAT opened at $2.92 on Friday. The stock has a 50 day simple moving average of $2.85 and a 200 day simple moving average of $3.37. Health Catalyst, Inc. has a 52-week low of $2.02 and a 52-week high of $9.24. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.88 and a current ratio of 1.88. The firm has a market capitalization of $206.53 million, a PE ratio of -1.84 and a beta of 1.64.

Health Catalyst (NASDAQ:HCAT) last announced its earnings results on Monday, November 10th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.05 by $0.01. The firm had revenue of $76.32 million for the quarter, compared to the consensus estimate of $75.05 million. Health Catalyst had a negative net margin of 34.05% and a negative return on equity of 6.67%. Health Catalyst has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Sell-side analysts predict that Health Catalyst, Inc. will post -0.33 EPS for the current fiscal year.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.